Explore the latest market price of generic medicines of sotorasibu (AMG510)

Sotoracib (AMG510), a revolutionary drug targeting KRAS G12C mutations, has been approved by the U.S. Food and Drug Administration (FDA), providing new hope for patients with locally advanced or metastatic non-small cell lung cancer who have experienced multiple treatments. As a highly effective oral small molecule targeted inhibitor, sotoraxib can precisely target and inhibit the KRAS G12C mutation, thereby effectively blocking the growth path of tumors. Its excellent anti-tumor activity and good tolerability demonstrated in clinical trials have undoubtedly further consolidated its position in the therapeutic field.

As the efficacy of sotoracib becomes more and more prominent, many pharmaceutical companies have joined the production of generic drugs. At present, in addition to the original research manufacturer Amgen of the United States, which is firmly occupying a place in the market, Lucious Pharmaceuticals of Laos, Daxiong Pharmaceuticals, and Everest Pharmaceuticals of Bangladesh have also emerged as important participants in the generic drug market of sotorasibu. These companies strictly abide by various production standards and regulations during the production process, and strive to be consistent with the original drugs in terms of quality, safety and efficacy.

In terms of price, each generic drug manufacturer has formulated different selling strategies based on its own production costs, market positioning and other factors, which helps patients make more economical and reasonable drug purchasing decisions. According to the latest market news, the price of the 120mg*56 tablet sotorasibu generic drug produced by Lucius Pharmaceuticals in Laos has been reduced to more than 1,000 yuan; similar products from Daxiong Pharmaceutical are priced at more than 2,000 yuan; while the price of Everest Pharmaceuticals in Bangladesh is relatively high and remains at the level of 4,000 yuan (actual prices may change due to exchange rate fluctuations and other factors).